Cenplacel-L (Celularity)

N/A

Report date: 2023/01/12 16:08:14

Base Information

Drug NameCenplacel-L (Celularity)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Placenta-derivedCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsStrokeInfarction, Posterior Cerebral ArteryInfarction, Middle Cerebral Artery +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene CorpCelularity Inc
Active IndicationsN/A
Inactive IndicationsStrokeInfarction, Posterior Cerebral ArteryInfarction, Middle Cerebral Artery +[5] 

Other Information

ATC CodeN/A
Related LinksN/A